Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Roche’s subcutaneous Ocrevus granted MHRA approval to treat relapsing and primary MS

The NHS said it expects stock of the ten-minute injection to be available in the coming weeks

- PMLiVE

Novo Nordisk’s Ozempic associated with cognitive benefits in diabetes patients

Researchers from the University of Oxford analysed records from more than 100 million patients in the US

- PMLiVE

Immutep’s LAG-3 immunotherapy candidate shows promise in head and neck cancer

Approximately 600,000 new cases of head and neck squamous cell carcinoma are diagnosed globally every year

- PMLiVE

Phesi publishes new analysis revealing top five most studied diseases globally

The analysis also showed that 32% of phase 2 trials were terminated in the first half of 2024

- PMLiVE

Chiesi’s rare disorder therapies approved by SMC for Fabry disease and epidermolysis bullosa

Rare diseases currently affect around 436,000 people living in Scotland

- PMLiVE

uniQure’s investigational gene therapy shown to slow Huntington’s disease progression

The neurodegenerative disorder affects approximately 70,000 people in Europe and the US

- PMLiVE

Francis Crick Institute appoints Edith Heard as new director and chief executive

The current director-general of the European Molecular Biology Laboratory will take on the role next year

- PMLiVE

AstraZeneca selects WPP as primary network for global oncology business

A bespoke WPP team will bring together experts from the organisation's global network

- PMLiVE

Ipsen gains global rights to Foreseen’s ADC candidate in deal worth up to $1.03bn

FS001 is currently completing the final stages of preclinical development

- PMLiVE

Almirall announces NICE recommendation for Ebglyss in atopic dermatitis

The inflammatory skin condition affects about 5.2 million adults and 2.5 million children in the UK

- PMLiVE

WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer

In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally

- PMLiVE

Hologic survey reveals major screening action gap in millions of US women

An estimated 72 million women in the US have skipped or delayed recommended preventative screening

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links